Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 14/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30426151 | 1.00 | GPR84 (0.52) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL27539091 | 0.90 | GPR84 (0.57) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL29415555 | 0.90 | GPR84 (0.57) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL5804639 | 0.90 | GPR84 (0.57) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL14525424 | 0.89 | GPR84 (0.47) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL9308176 | 0.84 | GPR84 (0.56) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL4103873 | 0.80 | GPR84 (0.48) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL28372852 | 0.80 | GPR84 (0.44) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL28420768 | 0.80 | GPR84 (0.41) | GPR84MEN1KMT2AKDM4ERECQL | |
| SCHEMBL29519147 | 0.79 | GPR84 (0.35) | GPR84MEN1KMT2AKDM4EHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001019792-A1 | COVALENTLY LINKED DIMERIC DNA BINDING MOLECULES | GENELABS TECHNOLOGIES, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| WO-1989005794-A1 | NOVEL ANTIARRHYTHMIC AGENTS I | Aktiebolaget Hässle (SE) | 1989-06-29 | — | — | WO | claimed |
| EP-0322390-A2 | Novel antiarrhythmic agents I | Aktiebolaget Hässle (SE) | 1989-06-28 | — | — | EP | claimed |
| US-20240066509-A1 | CHIRAL PHOSPHORIC ACIDS IMMOBILIZED ON SOLID SUPPORT FOR THE SELECTIVE PROTECTION OF HYDROXYL GROUPS | REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-02-29 | — | — | US | disclosed |
| US-20240066509-A1 | CHIRAL PHOSPHORIC ACIDS IMMOBILIZED ON SOLID SUPPORT FOR THE SELECTIVE PROTECTION OF HYDROXYL GROUPS | REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-02-29 | — | — | US | disclosed |
| WO-2023094526-A1 | PREPARATION PROCESS OF P(=O)-HETEROATOM DERIVATIVES OF DIBENZOOXAPHOSPHACYCLES | AIMPLAS ASOCIACIÓN DE INVESTIGACIÓN DE MATERIALES PLÁSTICOS Y CONEXAS (ES) | 2023-06-01 | — | — | WO | disclosed |
| EP-4186912-A1 | PREPARATION PROCESS OF P(=O)-HETEROATOM DERIVATIVES OF DIBENZOOXAPHOSPHACYCLES | AIMPLAS - Asociación de Investigación de Materiales Plásticos y Conexas (ES) | 2023-05-31 | — | — | EP | disclosed |
| EP-3541776-B1 | NOVEL PROCESS FOR THE MANUFACTURE OF GAMMA, DELTA-UNSATURATED KETONES | DSM IP ASSETS BV (NL) | 2020-12-23 | — | — | EP | disclosed |
| EP-3541776-B1 | NOVEL PROCESS FOR THE MANUFACTURE OF GAMMA, DELTA-UNSATURATED KETONES | DSM IP ASSETS BV (NL) | 2020-12-23 | — | — | EP | disclosed |
| WO-2020007342-A1 | APPLICATION OF BIPHENYL PHOSPHATE COMPOUND AS GPR84 ANTAGONIST | 中国科学院上海药物研究所 | 2020-01-09 | — | — | WO | disclosed |
| EP-3541776-A1 | NOVEL PROCESS FOR THE MANUFACTURE OF GAMMA, DELTA-UNSATURATED KETONES | DSM IP Assets B.V. (NL) | 2019-09-25 | — | — | EP | disclosed |
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| WO-2001019792-A1 | COVALENTLY LINKED DIMERIC DNA BINDING MOLECULES | GENELABS TECHNOLOGIES, INC. (US) | 2001-03-22 | — | — | WO | disclosed |
| EP-0322390-B1 | NOVEL ANTIARRHYTHMIC AGENTS I | Aktiebolaget Hässle (SE) | 1992-11-11 | — | — | EP | disclosed |
| US-5155133-A | Antiarrhythmic compounds and pharmaceutical compositions and methods thereof | AKTIEBOLAGET HASSLE (SE) | 1992-10-13 | — | — | US | disclosed |
| WO-1989005794-A1 | NOVEL ANTIARRHYTHMIC AGENTS I | Aktiebolaget Hässle (SE) | 1989-06-29 | — | — | WO | disclosed |
| EP-0322390-A2 | Novel antiarrhythmic agents I | Aktiebolaget Hässle (SE) | 1989-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240066509-A1 | CHIRAL PHOSPHORIC ACIDS IMMOBILIZED ON SOLID SUPPORT FOR THE SELECTIVE PROTECTION OF HYDROXYL GROUPS | PYGL, PSPH, HAO2 | GPR84 852/4885MEN1 4402/4885KMT2A 1501/4885 |
| US-20070142639-A1 | Process for production of amines | SMS, CCNT1, PEAK1 | GPR84 2711/4885MEN1 194/4885KMT2A 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.